|
Volumn 31, Issue 7, 1999, Pages 2763-2764
|
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
15 DEOXYSPERGUALIN;
AZATHIOPRINE;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE;
MIZORIBINE;
OKT 3;
TACROLIMUS;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPLICATION;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AZATHIOPRINE;
CREATININE;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
KIDNEY TRANSPLANTATION;
METHYLPREDNISOLONE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RIBONUCLEOSIDES;
TACROLIMUS;
TREATMENT OUTCOME;
|
EID: 0032749534
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(99)00558-8 Document Type: Conference Paper |
Times cited : (3)
|
References (6)
|